Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Corifollitropin Alfa (MK-8962) for Controlled Ovarian Stimulation in India
NCT01599494Phase 3Withdrawn
- Sponsor
- Organon & Co.
- Start
- Mar 2014
- Primary completion
- May 2015
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
01
Overview
A Phase 3 trial of corifollitropin alfa in infertility, sponsored by Organon & Co.. Planned start Mar 2014; status: withdrawn.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01599494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599494.